Cargando…
The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study
OBJECTIVE: To find out how bacterial lung infections (BLI) affect the effectiveness of therapy and the rate of pneumonia caused by pneumonia related to checkpoint inhibitors (CIP) in patients with non-small cell lung cancer (NSCLC) who are getting immunotherapy with checkpoint inhibitors (ICIs). PAT...
Autores principales: | Cao, Qiang, Wu, Xinyan, Chen, Yuquan, Wei, Qi, You, Yanwei, Qiang, Yi, Cao, Guangzhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497767/ https://www.ncbi.nlm.nih.gov/pubmed/37712056 http://dx.doi.org/10.3389/fcimb.2023.1257638 |
Ejemplares similares
-
Analysis of Gut Microbiota Signature and Microbe-Disease Progression Associations in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Xi, Yu, et al.
Publicado: (2022) -
Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer
por: He, Jia-Qi, et al.
Publicado: (2022) -
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
por: Cao, Qiang, et al.
Publicado: (2023) -
Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review
por: Wu, Xinyan, et al.
Publicado: (2023) -
Increased Cytokine Levels Assist in the Diagnosis of Respiratory Bacterial Infections or Concurrent Bacteremia in Patients With Non-Hodgkin’s Lymphoma
por: Zhang, Lihua, et al.
Publicado: (2022)